| Literature DB >> 28724176 |
R A Condorelli1, S La Vignera, L M Mongioì, S G Vitale, A S Laganà, L Cimino, A E Calogero.
Abstract
Myo-inositol (MYO) usually represents a therapeutic option for female infertility associated with insulin resistance. Recently, several evidences are accumulating about the potential use of MYO for the treatment of male infertility. This article summarizes the rationale for MYO in the treatment of male infertility. In particular, it illustrates the potential antioxidant and prokinetic role of MYO, and its importance for the modulation of hormonal regulation. In the final part of the manuscript has been added a proposal for a clinical algorithm reserved for patients with asthenozoospermia, where probably MYO could exert specific pharmacological effects.Entities:
Mesh：
Substances：
Year: 2017 PMID： 28724176
Source DB: PubMed Journal: Eur Rev Med Pharmacol Sci ISSN： 1128-3602 Impact factor: 3.507